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4-weekly used by our local hospitals and clinics be changed
to 1,2 MU 3-weekly as recommended by the WHO. This
latter regimen has been shown to protect against
recurrences in clinical trials. Further studies should be
performed to clarify which are the best antibiotic regimens
for secondary prophylaxis of rheumatic fever. The findings of
this study suggest that benzathine penicillin 1,8 MU
4-weekly may protect against recurrences even though
patients may not have therapeutic serum penicillin
concentrations. Such studies should include measurement
of both clinical and pharmacological parameters in the same
cohort of patients followed up for at least 5 years to
document recurrence rates.
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A randomised clinical trial
E. T. M. De Jonge, R. C. Pattinson, J. D. Makin,
C. P. Venter
Objective. To compare evacuation under systemic
analgesia (fentanyl and midazolam) in a treatment room
(ward group) with evacuation under general anaesthesia in
theatre.
Design. A prospective randomised clinical trial.
Setting. A tertiary medical centre serving a black urban
population.
Subjects. One hundred and forty-two patients with
uncomplicated incomplete abortions.
Intervention. Randomisation into two groups, those for
evacuation under systemic analgesia and those for
evacuation under general anaesthesia.
Main outcome measures. Both groups were compared
in terms of safety, efficacy, acceptability, blood
consumption and time delay between admission and
evacuation.
Results. Significantly less blood was used in the ward
group (37 units for 13 patients) than in the theatre group
(65 units for 24 patients) (P < 0,03). Significantly less time
was taken between admission and evacuation in the ward
group (median 7 hours 15 minutes) than in the theatre
group (median 12 hours 38 minutes) (P < 0,0003)..
Evacuation under fentanyl and midazolam was safe,
effective and acceptable for the majority of patients
compared with evacuation under general anaesthesia.
Conclusion. Patients with uncomplicated incomplete
abortions (uterine size equivalent to a pregnancy of 14
weeks' duration or less) can undergo evacuation safely
and effectively under fentanyl and midazolam and have a
significantly smaller chance of requiring a blood
transfusion.
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Hb = haemoglobin concentration; SO = standard deviation; NS = not significant
Results
Table I. Comparative results between evacuations done in a
treatment room (ward) and in theatre
5 - very severe); requirement for blood transfusion; and the
need for re-evacuation. Acceptability was evaluated by an
observer not directly involved in the surgical procedure.
From a pilot study we estimated that to show a difference
of 50% between the two groups in terms of blood
requirements, we would need 91 patients in each group
(power =80%, ~ = 0,2; error risk of 0,05, a =0,05). The
number of patients requiring blood transfusions was used as
the· end-point because it was objective, easily documented
and clinically important. The data were analysed using
standard statistical techniques. Categorical data were
compared using the X2-test. Where data were not normally
distributed, the Mann-Whitney U-test was used. A P-val~e


















Time delay from admission to. evacuation
Median 7 h 15 min 12 h 38 min
Range 15 min - 1 h 5 min -




A total of 142 patients was included in the study be~een
February and May 1992, of whom 73 were randomised to
the ward group and 68 to the theatre group. The sample size
of 182 could not be achieved because of hospital strikes
and unrest.
Results for the ward and the theatre group are
summarised and compared in Table I. Procedure-related
complications, namely uterine or viscous perforation or any
complication leading to hysterectomy, did not occur in either
group. Blood loss greater than 500 ml occurred in 2 of the
theatre cases. In 1 patient who underwent evacuation under
systemic analgesia the oxygen saturation dropped to 79%
during the operation; this was corrected by repositioning the
patient's head, with immediate normalisation of the
condition. None of the patients in either group had to be re-
evacuated and in all cases the postoperative course was
uncomplicated. The acceptability of the procedure is
presented in Table 11.
Mean age (yrs) 24
Hb (gldl) (mean ± SO)
On admission 10,8 ± 2,46
After evacuation 10,8 ± 2,86
Evacuation of the uterine cavity after an incomplete abortion
is done according to techniques described in standard
gynaecological textbooks and is usually performed under
general anaesthesia.' Over-occupancy of gynaecological
beds (129%), a high turnover of gynaecology patients (3 339
gynaecological emergency admissions for 1991),
overbooking of the emergency theatre and a shortage of
theatre nursing staff forced us to investigate evacuation of
uterine contents in a treatment room under systemic
analgesia. A combination of pethidine hydrochloride and
diazepam was initially used. During the initial period very few
patients needed to be re-evacuated and there were no
serious complications.
On the basis of our undocumented experience with
evacuation under systemic analgesia, we decided to
perform a randomised clinical trial to test the following
hypotheses: (i) evacuation under systemic analgesia for
uncomplicated incomplete abortion is safe, effective and
acceptable for the patient; (ilj the delay between admission
and the evacuation procedure is shorter for ward
evacuations than for evacuations done in theatre; and
(iH) blood loss for the ward group is less than for the theatre
group.
Patients and methods
Permission for the study was given by the Kalafong Hospital
Ethics Committee and written consent was obtained from
each patient before entry to the study. Only patients fulfilling
the following criteria were included in the study: uterine size
equivalent to a pregnancy duration of 14 weeks or less, a
dilated cervical canal, a haemoglobin concentration more
than 8 g/dl after resuscitation and no signs of sepsis
(temperature> 37,5°C, foul-smelling vaginal discharge). No
patient refused to participate. Randomisation was done
using numbered sealed opaque envelopes drawn by the
clinician on a consecutive basis.
Sedation was provided by an opioid analgesic, fentanyl,
and a benzodiazepine, midazolam. For the ward evacuation
the analgesic technique was as follows: pre-oxygenation for
at least 3 minutes with 6 - 7 litres oxygen delivered through
a close-fitting mask; fentanyl 1,5 I-Ig/kg given slowly
intravenously up to a maximum of 100 I-Ig, followed by
midazolam administered slowly intravenously and titrated
against the consciousness level of the patient to a maximum
of 15 mg. Oxygenation was monitored by pulse-oximetry for
the entire procedure. The anaesthetic technique for the
evacuation in theatre was: pre-oxygenation; thiopentone.
3,0 - 5,0 mg/kg intravenously, succinyldicholine 1,0 mg/kg
intravenously; routine intubation because none of the
patients was starved; inhalation of oxygen and nitrous oxide
(50/50) 70 mVkg and halothane 0,5 - 1,0% with spontaneous
respiration. All the evacuations, both in the ward and in
theatre, were performed with a sharp curette by a trained
house officer or registrar.
Both groups were evaluated in terms of delay between
admission and evacuation; complications (anaesthetic- and
procedure-related); acceptability, measured retrospectively
by the level of fear and/or pain experienced by the patient
(grading: 1 - none; 2 - mild; 3 - moderate; 4 - severe;
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Table 11. Comparison of acceptability between the ward and the
theatre group'
This randomised clinical trial demonstrated that
evacuation of uterine contents in patients with an
incomplete abortion and uterine size equivalent to less than
14 weeks' gestation could be performed safely and
effectively in a well-equipped treatment room under
systemic analgesia, with fewer patients requiring blood
transfusion. Systemic analgesia appeared to be acceptable
to the majority in terms of experience of pain.
Studies on evacuation of incomplete abortion under
systemic analgesia2-4 have concluded that this procedure is
safe, effective, easy to perform and acceptable to the
majority of patients. Different analgesic techniques were
used. In the studies by Filshie et at! and Verkuyl and
Crowther' a combination of pethidine and diazepam was
used, and in the study by O'Dowd and Sil3 ketamine was
used as a sole agent. We used fentanyl for its potent
analgesic properties and midazolam because it has a short
half-life and the patients were likely to benefit from its
properties of retrograde amnesia. However, the danger of
respiratory depression still exists, and the evacuation room
must therefore be equipped with a resuscitation unit and a
pulse-oximeter for continuous oxygen saturation monitoring.
Evacuation in such a treatment room was shown to be as
safe as evacuation in theatre under general anaesthesia.
There was less need for blood transfusion in the ward
group than in the theatre group (Table I), but the reason for
this is uncertain. There are two probable explanations:
(i) ward patients were evacuated much earlier after
admission than those waiting for an evacuation in theatre, as
was clearly demonstrated; and (ii) anaesthetic age.nts such
as halothane and/or nitrous oxide are known to cause
uterine relaxation, and might have been responsible for the
higher blood requirements in the theatre group. Since the
pre- and postoperative haemoglobin concentrations were
similar in both groups, bias is a very unlikely third possibility.
Assessment of pain is notoriously difficult and by its
nature is subjective. In 2 patients (2,7%) (Table 11) the
procedure was clearly unacceptable; however, in the
remainder acceptability depends on what is defined by the
Discussion
• For interpretation see 'Discussion'.
t For definition see 'Pa:ients and methods'.
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individual doctor (and patient) as acceptable. Stated more
precisely, is moderate experience of pain by the patient
acceptable? If a moderate level of pain is acceptable for this
procedure, acceptable pain levels 1 - 3 would be compared
with unacceptable levels 4 and 5. In this case there is no
significant difference between the ward and the theatre
groups (P = 0,17). On the other hand, if moderate
expe~ience of pain during the evacuation procedure is not
considered acceptable, and pain levels 1 and 2 are therefore
compared with levels 3 - 5, there is a significant difference
between the ward and the theatre group (P < 0,04), with the
ward group having more substantial pain. Keeping in mind
that pain tolerance varies according to the individual we are
satisfied with the analgesic potential of the combination of
fentanyl and midazolam. It also compares favourably with
the study of Filshie et al.; in which 4 of 121 patients (3,3%)
said they had experienced pain during the procedure
performed under pethidine and diazepam. It is interesting to
note from this study that 97 of the 99 patients who were
available for their 6-weeks follow-up visit were pleased that
they had not had general anaesthesia; only 2 would have
preferred it. We realise that this outcome may be biased.
In terms of costs, ward evacuation is much more
economical than theatre evacuation. From our data we
calculated the hospital costs (Transvaal Provincial
Administration tariffs) to be R433,72 per patient for an
evacuation in the ward (hospitalisation at R266,50 per day =
R333,00; blood at R150,00 per unit = R84,00; fentanyl and
midazolam 1 ampoule each R16,72) and R860,69 for an
evacuation in theatre (hospitalisation R422,00; blood
R134,69; theatre fee R281 ,00; thiopentone and
succinydicholine R23,00), a difference of R426,97 per
patient. In 1991, 868 ward evacuations were performed at
Kalafong, saving R370 609,96 (R426,97 x 868) on the
hospital budget.
In 'conclusion, uncomplicated incomplete abortions with a
uterine size equivalent to a pregnancy of up to 14 weeks'
duration can be evacuated safely and effectively in a ward
treatment room under fentanyl and midazolam, provided the
patient is well resuscitated pre-operatively and respiratory
depression can be diagnosed early by monitoring the
oxygen saturation. Patient care can be improved by
searching for the most safe and effective combination of
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